The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-(4-(3-(2,6-dioxopiperazin-1-yl)propyl)piperazin-1-yl)propyl)piperazine-2,6-dione ID: ALA4091722
PubChem CID: 137653902
Max Phase: Preclinical
Molecular Formula: C18H30N6O4
Molecular Weight: 394.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1CNCC(=O)N1CCCN1CCN(CCCN2C(=O)CNCC2=O)CC1
Standard InChI: InChI=1S/C18H30N6O4/c25-15-11-19-12-16(26)23(15)5-1-3-21-7-9-22(10-8-21)4-2-6-24-17(27)13-20-14-18(24)28/h19-20H,1-14H2
Standard InChI Key: UGMKYQUIKXYRDV-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
3.0854 -14.5573 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9025 -14.5461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3207 -15.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1379 -15.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5561 -15.9390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1563 -16.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5710 -17.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3885 -17.3411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7896 -16.6280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3731 -15.9218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8041 -18.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6213 -18.0366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0369 -18.7402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8540 -18.7321 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6670 -13.8550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8534 -13.8642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4507 -14.5756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8677 -15.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6875 -15.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2658 -19.4356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0794 -19.4295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4848 -18.7195 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0704 -18.0141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2507 -18.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0667 -13.1422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1048 -15.9745 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8620 -20.1460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8344 -17.3154 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
8 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
1 15 1 0
1 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
14 20 1 0
14 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
15 25 2 0
19 26 2 0
20 27 2 0
24 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.48Molecular Weight (Monoisotopic): 394.2329AlogP: -2.70#Rotatable Bonds: 8Polar Surface Area: 105.30Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.77CX LogP: -3.40CX LogD: -3.93Aromatic Rings: ┄Heavy Atoms: 28QED Weighted: 0.43Np Likeness Score: -0.66
References 1. Kumar A, Banerjee S, Roy P, Sondhi SM, Sharma A.. (2017) Solvent free, catalyst free, microwave or grinding assisted synthesis of bis-cyclic imide derivatives and their evaluation for anticancer activity., 27 (3): [PMID:28011220 ] [10.1016/j.bmcl.2016.12.031 ]